SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-19-000070
Filing Date
2019-05-17
Accepted
2019-05-17 16:34:57
Documents
2
Period of Report
2019-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155812528169706.html 4  
1 FORM 4 wf-form4_155812528169706.xml 4 5138
2 DUNSIRE POA dunsirepoa.htm EX-24 3068
  Complete submission text file 0000899866-19-000070.txt   9667
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Dunsire Deborah (Reporting) CIK: 0001332764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 19836264